Skip to content

Apixaban

Apixaban (Eliquis) is an oral anticoagulant used to reduce the risk of stroke and treat or prevent blood clots. This catalogue lists the Eliquis film-coated tablet.

Medicine containing Apixaban

Eliquis

Deep Vein Thrombosis, Stroke Prevention

2.5mg · 5mg

Apixaban tablets for preventing blood clots and stroke. Unlike warfarin, they do not need routine blood monitoring.

From$3.33/ tabletView

Key points

  • How your liver processes it: apixaban is metabolised mainly through the CYP3A4 enzyme.
  • Bleeding-related reactions: these can include gum bleeding, nosebleeds, bruising, blood in the urine, rectal bleeding, heavier menstrual bleeding and coughing up blood.
  • Stopping early: stopping Eliquis early, other than because of a bleeding problem or after planned treatment ends, raises the risk of a blood clot.

How Apixaban works

Apixaban is a direct-acting oral anticoagulant, also called a DOAC, and a factor Xa inhibitor. Factor Xa is a clotting protein involved in producing thrombin, which makes clots grow. By blocking it, apixaban reduces thrombin production and slows clot growth. It does not directly act on platelets.

Further reading

Last updated